Executive Steering News Today

It's time again to check the pulse — of Florida's health care policy and politics.

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Desi...

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today

Investegate announcements from Clariant International Ltd, Clariant’s shareholders approve all agenda items

Integrated Report, Financial Statements and Consolidated Financial Statements of Clariant for the fiscal year 2022 approvedIncreased distribution of CHF 0.42 per share confirmedProposed amendments to the

The projected total cost of the bi-state Interstate Bridge Replacement program is $6 billion, according to Greg Johnson, Interstate Bridge Replacement

The project team received approval from local governments and agencies to move the preliminary design into the next phase of development.

The government on Thursday approved, through a memorandum, the negotiation of the Loan Agreement with the International Bank for Reconstruction and...

The project team unveiled most of its remaining high-level design choices at a meeting on Thursday, including the number of lanes on the bridge.

The project team unveiled most of its remaining high-level design choices at a meeting on Thursday, including the number of auxiliary lanes on the bridge.